Neurobit is a biomedical innovation and neurotechnology company based in Taipei City. The company specializes in intelligent healthcare platforms that utilize visual physiological signals and sleep data for the early detection, diagnosis, and risk prediction of neurological and cardiovascular conditions. By integrating advanced AI, eye movement analysis, and wearable sleep technology, Neurobit aims to improve clinical decision-making and preventive care.
Neurobit offers a variety of products in two main areas: sleep technology and ocular motor diagnostics. Their sleep analytics platforms, including the Neurobit HUB and Neurobit PSG, provide accurate sleep scoring and health analytics for healthcare providers and researchers. In the realm of neurological diagnostics, devices like Neurospeed enable the recording and analysis of eye movements, facilitating early detection of conditions such as stroke and other brain diseases. Neurobit’s solutions are certified for medical use and are utilized by over 150 institutions worldwide, including clinics, hospitals, and research centers.
